HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MOH
Molina Healthcare, Inc.
MOH lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MOH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
MOH's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MOH PE Valuation
MOH has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MOH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
MOH has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over MOH on earnings, with more consistent year-over-year improvement.
MOH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.35 | — |
| Q3 2026 | -$0.60 | -104% |
| Q2 2026 | $0.18 | -99% |
| Q1 2026 | $3.74 | -82% |
| Q4 2025 | $8.92 | -56% |
| Q3 2025 | $16.14 | -18% |
| Q2 2025 | $20.28 | +11% |
| Q1 2025 | $20.70 | +12% |
| Q4 2024 | $20.42 | +8.8% |
MOH has swung to a loss: it lost $0.60 per share over the past year, after a profit the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over MOH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
MOH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1B | -3.4% |
| Q2 2026 | $10.9B | -4.8% |
| Q1 2026 | $10.8B | -3.1% |
| Q4 2025 | $11.4B | +8.3% |
| Q3 2025 | $11.5B | +11% |
| Q2 2025 | $11.4B | +16% |
| Q1 2025 | $11.1B | +12% |
| Q4 2024 | $10.5B | +16% |
MOH's revenue grew through 2024 and has held roughly level since: $11.1B last quarter, down 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1% | -0.2 points |
| Q2 2026 | 1.3% | -1.9 points |
| Q1 2026 | 0.8% | -3.1 points |
| Q4 2025 | -1.4% | -5 points |
| Q3 2025 | 1.2% | -3.3 points |
| Q2 2025 | 3.3% | -1.1 points |
| Q1 2025 | 3.9% | -0.4 points |
| Q4 2024 | 3.6% | +0.1 points |
MOH has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over MOH on cash flow, with more consistent year-over-year improvement.
MOH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$196M | -$33M |
| Q2 2026 | -$324M | +$20M |
| Q1 2026 | $1.1B | +528% |
| Q4 2025 | -$297M | -$62M |
| Q3 2025 | -$163M | -119% |
| Q2 2025 | -$344M | -$98M |
| Q1 2025 | $168M | -10% |
| Q4 2024 | -$235M | +$450M |
MOH's free cash flow has turned positive after two years mostly in the red: $238M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MOH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MOH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +200K shares |
| 1 year | -1.9% | -1M shares |
| 3 years | -11% | -6.6M shares |
| 5 years | -12% | -7M shares |
| Available history | -20% | -12.7M shares |
MOH has 52M diluted shares, down 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $500M |
| Q2 2025 | — |
| Q1 2025 | $500M |
| Q4 2024 | $500M |
MOH hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MOH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -3.3x | Net Cash |
| Q1 2026 | -2.5x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
MOH has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MOH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 55.8 | Neutral |
MOH's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MOH PE vs Healthcare Sector
| Metric | MOH | Sector median | Relative |
|---|---|---|---|
| PE | 1,152x | 26x | 4,356% above |
| PE % | 100 | 29 | 71 pts above |
MOH has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MOH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.2 | 3.8% above |
| 20 week MA | $205.7 | 2% above |
| 50 week MA | $183.7 | 14% above |
| 100 week MA | $216.0 | 2.9% below |
| 200 week MA | $271.6 | 23% below |
MOH has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
MOH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $136.1 | $207.1 | +52% |
| 2021 | $207.1 | $316.7 | +53% |
| 2022 | $316.7 | $335.1 | +5.8% |
| 2023 | $335.1 | $361.3 | +7.8% |
| 2024 | $361.3 | $292.2 | -19% |
| 2025 | $292.2 | $164.8 | -44% |
| 2026 YTD | $164.8 | $209.9 | +27% |
MOH has the edge over HIMS on returns for 2026, with the stronger performance.